[go: up one dir, main page]

DE69328550D1 - Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln - Google Patents

Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln

Info

Publication number
DE69328550D1
DE69328550D1 DE69328550T DE69328550T DE69328550D1 DE 69328550 D1 DE69328550 D1 DE 69328550D1 DE 69328550 T DE69328550 T DE 69328550T DE 69328550 T DE69328550 T DE 69328550T DE 69328550 D1 DE69328550 D1 DE 69328550D1
Authority
DE
Germany
Prior art keywords
diagnostic
pct
therapeutic agents
fulleren
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328550T
Other languages
English (en)
Other versions
DE69328550T2 (de
Inventor
D Watson
Jo Klaveness
C Jamieson
Douglas Fellmann
Blane Vogt
R Cockbain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amersham Health Salutar Inc
Original Assignee
Nycomed Salutar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Salutar Inc filed Critical Nycomed Salutar Inc
Application granted granted Critical
Publication of DE69328550D1 publication Critical patent/DE69328550D1/de
Publication of DE69328550T2 publication Critical patent/DE69328550T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1268—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
    • A61K49/0084—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion liposome, i.e. bilayered vesicular structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/189—Host-guest complexes, e.g. cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/228—Host-guest complexes, clathrates, chelates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nanotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Acoustics & Sound (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DE69328550T 1992-02-11 1993-02-11 Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln Expired - Lifetime DE69328550T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929203037A GB9203037D0 (en) 1992-02-11 1992-02-11 Contrast agents
PCT/GB1993/000279 WO1993015768A1 (en) 1992-02-11 1993-02-11 Use of fullerenes in diagnostic and/or therapeutic agents

Publications (2)

Publication Number Publication Date
DE69328550D1 true DE69328550D1 (de) 2000-06-08
DE69328550T2 DE69328550T2 (de) 2001-02-08

Family

ID=10710315

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328550T Expired - Lifetime DE69328550T2 (de) 1992-02-11 1993-02-11 Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln

Country Status (8)

Country Link
US (1) US5688486A (de)
EP (1) EP0625055B1 (de)
JP (1) JPH07506092A (de)
AT (1) ATE192339T1 (de)
AU (1) AU3506893A (de)
DE (1) DE69328550T2 (de)
GB (1) GB9203037D0 (de)
WO (1) WO1993015768A1 (de)

Families Citing this family (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
EP0660834A1 (de) * 1992-09-08 1995-07-05 Hoechst Aktiengesellschaft Neue fulleren-derivate, verfahren zur herstellung und deren verwendung
DE4339053A1 (de) * 1992-12-15 1994-06-16 Franz Dietrich Oeste Mit Wirkstoffen gefüllte Spheren, Verfahren zu ihrer Herstellung und Öffnung
AU7960094A (en) * 1993-10-04 1995-05-01 Mallinckrodt Medical, Inc. Compositions and methods for magnetic resonance imaging, x-ray imaging and radiopharmaceuticals
US5866434A (en) * 1994-12-08 1999-02-02 Meso Scale Technology Graphitic nanotubes in luminescence assays
WO1996024139A2 (en) * 1995-01-23 1996-08-08 Schaefer Daniel R Trapping and storage of free thermal neutrons in fullerene molecules
AU2426697A (en) * 1996-03-29 1997-10-22 Lawrence Berkeley National Laboratory Enhancement of nmr and mri in the presence of hyperpolarized noble gases
US6736769B2 (en) 1996-04-17 2004-05-18 Olivier Bertrand Radioactivity local delivery system
US5871436A (en) * 1996-07-19 1999-02-16 Advanced Cardiovascular Systems, Inc. Radiation therapy method and device
US5782740A (en) * 1996-08-29 1998-07-21 Advanced Cardiovascular Systems, Inc. Radiation dose delivery catheter with reinforcing mandrel
US6210312B1 (en) 1997-05-20 2001-04-03 Advanced Cardiovascular Systems, Inc. Catheter and guide wire assembly for delivery of a radiation source
WO1999004826A1 (en) * 1997-07-24 1999-02-04 The Australian National University Method for detection of fibrin clots
WO1999032184A1 (en) * 1997-12-19 1999-07-01 Cordis Corporation Catheter system having fullerenes and method
US6159140A (en) * 1998-02-17 2000-12-12 Advanced Cardiovascular Systems Radiation shielded catheter for delivering a radioactive source and method of use
US6159139A (en) * 1998-02-17 2000-12-12 Advanced Cardiovascular Systems Inc. Radiation delivery catheter with a spring wire centering mechanism
DE19816917A1 (de) * 1998-04-16 1999-10-28 Siemens Ag Verfahren zur räumlich aufgelösten Temperaturüberwachung, Suspension von ferromagnetischen Mikropartikeln und Verwendung dieser Suspension
GB2337050B (en) * 1998-05-04 2001-02-14 Chinese Petroleum Corp Fullerene-containing metallocene
WO2000006244A2 (en) * 1998-07-30 2000-02-10 Hainfeld James F Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy
US6355224B1 (en) 1998-09-17 2002-03-12 Massachusetts Institute Of Technology Conductive polymer contrast agent compositions and uses therefor
ATE383331T1 (de) 1998-11-12 2008-01-15 Invitrogen Corp Transportreagentien
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization
US20030073250A1 (en) * 1999-05-21 2003-04-17 Eric Henderson Method and apparatus for solid state molecular analysis
US6573369B2 (en) * 1999-05-21 2003-06-03 Bioforce Nanosciences, Inc. Method and apparatus for solid state molecular analysis
US20030186311A1 (en) * 1999-05-21 2003-10-02 Bioforce Nanosciences, Inc. Parallel analysis of molecular interactions
US20020042081A1 (en) * 2000-10-10 2002-04-11 Eric Henderson Evaluating binding affinities by force stratification and force panning
US6562295B1 (en) * 1999-06-30 2003-05-13 Ceramoptec Industries, Inc. Bacteria resistant medical devices
DE19936997B4 (de) * 1999-08-02 2007-06-14 Biolitec Ag Verfahren zur Applikation von Photosensibilisatoren (PS) mittels Multiplikatoren in der photodymamischen Therapie
US6582417B1 (en) 1999-09-22 2003-06-24 Advanced Cardiovascular Systems, Inc. Methods and apparatuses for radiation treatment
US6605031B1 (en) 1999-09-22 2003-08-12 Advanced Cardiovascular Systems, Inc. Stepped centering balloon for optimal radiation delivery
US6355225B1 (en) * 1999-10-05 2002-03-12 Wm. Marsh Rice University Tda Research, Inc. Fullerene contrast agent for magnetic resonance imaging and spectroscopy
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6540734B1 (en) 2000-02-16 2003-04-01 Advanced Cardiovascular Systems, Inc. Multi-lumen extrusion tubing
US7994449B2 (en) 2000-02-16 2011-08-09 Advanced Cardiovascular Systems, Inc. Square-wave laser bonding
US6897015B2 (en) * 2000-03-07 2005-05-24 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of pathogens and biological materials
US7037332B2 (en) * 2000-03-15 2006-05-02 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US20070055367A1 (en) * 2000-03-15 2007-03-08 Orbus Medical Technologies, Inc. Medical device with coating that promotes endothelial cell adherence and differentiation
US20030229393A1 (en) * 2001-03-15 2003-12-11 Kutryk Michael J. B. Medical device with coating that promotes cell adherence and differentiation
US8460367B2 (en) * 2000-03-15 2013-06-11 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US6471942B1 (en) 2000-04-20 2002-10-29 Luna Innovations, Inc. Imaging and treatment method for body
JP2003532648A (ja) * 2000-05-02 2003-11-05 ハーン−マイトネル−インスチツート ベルリン ゲゼルシャフト ミット ベシュレンクテル ハフツング 構造形成した分子配列及び量子力学的情報処理のためのその使用
US6928315B1 (en) 2000-05-21 2005-08-09 Mirabel Medical Systems Ltd. Apparatus for impedance imaging coupled with another modality
US7061237B2 (en) * 2000-07-13 2006-06-13 The Regents Of The University Of California Remote NMR/MRI detection of laser polarized gases
US6652833B2 (en) * 2000-07-13 2003-11-25 The Regents Of The University Of California Functionalized active-nucleus complex sensor
US20030165431A1 (en) * 2000-07-13 2003-09-04 The Regents Of The University Of California Method for detecting macromolecular conformational change and binding information
CN1261745C (zh) * 2000-08-15 2006-06-28 拜澳富斯毫微科学有限公司 纳米级分子阵列排布机
US6660248B2 (en) 2000-11-10 2003-12-09 William Marsh Rice University Fullerene (C60)-based X-ray contrast agent for diagnostic imaging
US20020177769A1 (en) * 2001-04-23 2002-11-28 The Regents Of The University Of California Method and apparatus for locating cells in the body by measuring magnetic moments
US20040038946A1 (en) * 2001-04-27 2004-02-26 Wilson Lon J. Fullerene-based drugs targeted to bone
US6878361B2 (en) * 2001-07-10 2005-04-12 Battelle Memorial Institute Production of stable aqueous dispersions of carbon nanotubes
AU2002329606A1 (en) * 2001-07-17 2003-03-03 Bioforce Nanosciences, Inc. Combined molecular blinding detection through force microscopy and mass spectrometry
US20040156852A1 (en) * 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
US7042488B2 (en) 2001-09-27 2006-05-09 Fujinon Corporation Electronic endoscope for highlighting blood vessel
AU2002334784A1 (en) 2001-10-01 2003-04-14 Tda Research, Inc. Derivatization and solubilization of insoluble classes of fullerenes
US7812190B2 (en) * 2001-10-01 2010-10-12 Tda Research, Inc. Derivatization and solubilization of fullerenes for use in therapeutic and diagnostic applications
US20030135195A1 (en) * 2002-01-16 2003-07-17 Oscar Jimenez Highly lubricious hydrophilic coating utilizing dendrimers
ES2233118B1 (es) * 2002-01-30 2006-07-16 Francisco Leon Prieto Sistema de administracion no intravenosa de un ligando especifico de celulas de epitelios, detectable por tecnicas de imagen y sus aplicaciones.
US20040166152A1 (en) * 2002-02-14 2004-08-26 Andreas Hirsch Use of buckysome or carbon nanotube for drug delivery
TW200307563A (en) * 2002-02-14 2003-12-16 Sixty Inc C Use of BUCKYSOME or carbon nanotube for drug delivery
US20080193490A1 (en) * 2002-02-14 2008-08-14 Andreas Hirsch Use of Carbon Nanotube for Drug Delivery
JP2005522471A (ja) * 2002-04-02 2005-07-28 バージニア テック インテレクチュアル プロパティーズ インコーポレーテッド 金属内包フラーレン造影剤
JP4667705B2 (ja) * 2002-04-26 2011-04-13 三菱電機株式会社 磁気的相互作用算出プログラム
US20050239193A1 (en) * 2002-05-30 2005-10-27 Bioforce Nanosciences, Inc. Device and method of use for detection and characterization of microorganisms and microparticles
AU2003248679A1 (en) * 2002-06-14 2003-12-31 Actinium Pharmaceuticals Ltd. Treating disease using radium-225
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
WO2004005289A2 (en) 2002-07-02 2004-01-15 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
US20040058457A1 (en) * 2002-08-29 2004-03-25 Xueying Huang Functionalized nanoparticles
US20040092807A1 (en) * 2002-11-07 2004-05-13 Amos Breskin System and method for cancer detection
WO2004060044A2 (en) * 2003-01-02 2004-07-22 Bioforce Nanosciences, Inc. Method and apparatus for molecular analysis in small sample volumes
US20040156846A1 (en) * 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles using L6 antibodies
KR100513089B1 (ko) 2003-09-23 2005-09-08 광주과학기술원 풀러렌계 나노구 및 그 제조방법
US20060247152A1 (en) * 2005-05-02 2006-11-02 Russ Lebovitz Substituted fullerenes and their use as inhibitors of cell death
US20050288236A1 (en) * 2003-10-10 2005-12-29 Russ Lebovitz Substituted fullerene formulations and their use in ameliorating oxidative stress diseases or inhibiting cell death
US7410699B2 (en) * 2003-10-10 2008-08-12 Japan Science And Technology Agency Finely particulate composite containing carbon compound encapsulated in a polymer micelle of a block copolymer
GB2413182A (en) * 2004-04-16 2005-10-19 Univ Southampton An NMR method for analysing a sample
TW200605910A (en) * 2004-04-30 2006-02-16 Orbus Medical Technologies Inc Medical device with coating for capturing genetically-altered cells and methods for using same
US20060039521A1 (en) 2004-06-22 2006-02-23 Schaefer Daniel R Direct production of thermal antineutrons and antiprotons
WO2006017333A2 (en) * 2004-07-13 2006-02-16 William Marsh Rice University Shortened carbon nanotubes
US20060280785A1 (en) * 2004-08-11 2006-12-14 Easterly Clay E Biocidal materials for treatment against pathogens
WO2006028635A2 (en) * 2004-09-02 2006-03-16 C Sixty Inc. Fullerene compositions for ameliorating hearing loss, collateral damage of chemotherapy, or mucositis
JP4822702B2 (ja) * 2004-12-24 2011-11-24 独立行政法人科学技術振興機構 造影剤
US20060140867A1 (en) * 2004-12-28 2006-06-29 Helfer Jeffrey L Coated stent assembly and coating materials
EA011594B1 (ru) * 2004-12-30 2009-04-28 Синвеншен Аг Композиция, включающая агент, обеспечивающий сигнал, имплантируемый материал и лекарство
DK1836239T3 (da) 2005-01-13 2009-01-19 Cinv Ag Kompositmaterialer, der indeholder carbonnanopartikler
DE102005005704B4 (de) * 2005-02-03 2010-08-12 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Verwendung von Partikeln für die Ermittlung der lokalen Temperatur in organischen und nichtorganischen Körpern
DE102005007223B4 (de) * 2005-02-15 2009-01-02 Helmholtz-Zentrum Berlin Für Materialien Und Energie Gmbh Verwendung eines endohedrale Fullerene enthaltendes Kontrastmittel für die Kernspintomographie unter Nutzung des Overhauser-Effekts
WO2006116021A2 (en) * 2005-04-22 2006-11-02 Intematix Corporation Mri technique based on electron spin resonance and endohedral contrast agent
CA2605763C (en) 2005-04-29 2014-02-11 The Australian National University A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
US8246917B2 (en) 2006-06-23 2012-08-21 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
CA2629685A1 (en) * 2005-07-22 2007-02-01 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers
US20070025918A1 (en) * 2005-07-28 2007-02-01 General Electric Company Magnetic resonance imaging (MRI) agents: water soluble carbon-13 enriched fullerene and carbon nanotubes for use with dynamic nuclear polarization
EP1937753A1 (de) * 2005-10-18 2008-07-02 Cinvention Ag Duroplastische teilchen und herstellungsverfahren dafür
US20080020977A1 (en) * 2005-11-21 2008-01-24 Russ Lebovitz Use of Fullerenes to Oxidize Reduced Redox Proteins
EP4272694A3 (de) 2006-04-20 2024-01-03 Sonendo, Inc. Vorrichtung zur behandlung von wurzelkanälen von zähnen
US10835355B2 (en) 2006-04-20 2020-11-17 Sonendo, Inc. Apparatus and methods for treating root canals of teeth
WO2007137256A2 (en) * 2006-05-22 2007-11-29 William Marsh Rice University Carbon nanotube based imaging agents
US8252772B2 (en) * 2006-05-25 2012-08-28 Wake Forest University Hyperthermic technologies and therapeutic uses thereof
WO2007143558A1 (en) * 2006-06-01 2007-12-13 William Marsh Rice University Targeted nanostructures for cellular imaging
CA2656648A1 (en) * 2006-06-23 2008-09-12 Johns Hopkins University Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery
US12114924B2 (en) 2006-08-24 2024-10-15 Pipstek, Llc Treatment system and method
US7980854B2 (en) 2006-08-24 2011-07-19 Medical Dental Advanced Technologies Group, L.L.C. Dental and medical treatments and procedures
US20100330539A1 (en) * 2006-08-24 2010-12-30 Medical Dental Advance Technologies Group Periodontal treatment system and method
US20080070195A1 (en) * 2006-08-24 2008-03-20 Divito Enrico E Energetically activated biomedical nanotheurapeutics integrating dental and medical treatments and procedures
EP2104473A1 (de) * 2007-01-19 2009-09-30 Cinvention Ag Durch pulverformung hergestelltes poröses und nicht abbaubares implantat
US20080206734A1 (en) * 2007-02-28 2008-08-28 Cinvention Ag High surface cultivation system with filler
WO2008104599A1 (en) * 2007-02-28 2008-09-04 Cinvention Ag High surface cultivation system bag
BRPI0807993A2 (pt) * 2007-02-28 2014-06-17 Cinv Ag Sistema de cultivo de alta superfície.
CA2677721A1 (en) * 2007-02-28 2008-09-04 Cinvention Ag High surface cultivation system with surface increasing substrate
WO2008154043A2 (en) * 2007-06-14 2008-12-18 The Board Of Trustees Of The University Of Arkansas Near-infrared responsive carbon nanostructures
WO2009059215A1 (en) * 2007-10-31 2009-05-07 University Of Florida Research Foundation, Inc. Use of fullerenes in photoacoustic imaging
US8187221B2 (en) * 2008-07-11 2012-05-29 Nexeon Medsystems, Inc. Nanotube-reinforced balloons for delivering therapeutic agents within or beyond the wall of blood vessels, and methods of making and using same
GB0820309D0 (en) * 2008-11-06 2008-12-17 Middlesex University Higher Ed Detection of cancer
DE102008043654A1 (de) * 2008-11-11 2010-05-20 Leibniz-Institut Für Festkörper- Und Werkstoffforschung Dresden E.V. Diagnostisches und/oder therapeutisches Agens, Verfahren zu seiner Herstellung und Verwendung
JP5463548B2 (ja) * 2009-09-08 2014-04-09 学校法人福岡大学 超音波治療用リポソーム及び超音波治療促進用リポソーム
CN102724929B (zh) 2009-11-13 2016-04-13 索南多股份有限公司 用于牙科治疗的液体射流设备和方法
US9125942B2 (en) * 2010-01-19 2015-09-08 Northwestern University Paramagnetic metal-nanodiamond conjugates
DE102010020567A1 (de) * 2010-05-14 2011-11-17 Merck Patent Gmbh Metallkomplexe
WO2012027556A1 (en) * 2010-08-25 2012-03-01 William Marsh Rice University Nanostructures comprising radioisotopes and/or metals
US8888879B1 (en) 2010-10-20 2014-11-18 Us Synthetic Corporation Detection of one or more interstitial constituents in a polycrystalline diamond element by neutron radiographic imaging
CN107115154B (zh) 2010-10-21 2021-06-15 索南多股份有限公司 用于牙髓治疗的设备、方法和组合
US9085463B2 (en) 2011-01-17 2015-07-21 Marelle, Llc Water-soluble functionalized fullerenes
US20140161733A1 (en) * 2011-03-30 2014-06-12 Luna Innovations Incorporated Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque
EP2836156B1 (de) 2012-03-22 2024-04-17 Sonendo, Inc. Vorrichtung zur zahnreinigung
US10631962B2 (en) 2012-04-13 2020-04-28 Sonendo, Inc. Apparatus and methods for cleaning teeth and gingival pockets
US10363120B2 (en) 2012-12-20 2019-07-30 Sonendo, Inc. Apparatus and methods for cleaning teeth and root canals
EP3943042B1 (de) 2012-12-20 2024-03-13 Sonendo, Inc. Vorrichtung zum reinigen der zähne und der zahnwurzelkanäle
US10722325B2 (en) 2013-05-01 2020-07-28 Sonendo, Inc. Apparatus and methods for treating teeth
EP3013277B1 (de) 2013-06-26 2023-07-19 Sonendo, Inc. Vorrichtung und verfahren zum füllen von zähnen und zahnwurzelkanälen
KR101612514B1 (ko) * 2014-06-16 2016-04-14 포항공과대학교 산학협력단 에멀젼을 이용한 탄소 양자점의 제조 방법
US10806544B2 (en) 2016-04-04 2020-10-20 Sonendo, Inc. Systems and methods for removing foreign objects from root canals
CN109096118B (zh) * 2017-06-21 2021-07-30 北京福纳康生物技术有限公司 胺基富勒烯衍生物及其制备方法和应用
USD997355S1 (en) 2020-10-07 2023-08-29 Sonendo, Inc. Dental treatment instrument

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122363A (en) * 1990-12-07 1992-06-16 Board Of Regents, The University Of Texas System Zeolite-enclosed transistion and rare earth metal ions as contrast agents for the gastrointestinal tract
US5248498A (en) * 1991-08-19 1993-09-28 Mallinckrodt Medical, Inc. Fullerene compositions for magnetic resonance spectroscopy and imaging
US5177248A (en) * 1991-10-28 1993-01-05 Exxon Research And Engineering Company Process of forming polysubstituted fullerenes

Also Published As

Publication number Publication date
EP0625055B1 (de) 2000-05-03
EP0625055A1 (de) 1994-11-23
ATE192339T1 (de) 2000-05-15
WO1993015768A1 (en) 1993-08-19
GB9203037D0 (en) 1992-03-25
DE69328550T2 (de) 2001-02-08
JPH07506092A (ja) 1995-07-06
AU3506893A (en) 1993-09-03
US5688486A (en) 1997-11-18

Similar Documents

Publication Publication Date Title
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
DK0733109T3 (da) BMP-12, BMP-13 og seneinducerende præparater dermed
CA2075060A1 (en) Novel vehicle gases and their use in medical preparations
NO308794B1 (no) Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse
EE9800223A (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69212620D1 (de) Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
SE9404196D0 (sv) New antithrombotic formulation
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
DE58906242D1 (de) 2,3-difluorbenzolderivate und ihre verwendung als komponenten flüssigkristalliner medien.
DE69528710D1 (de) 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung
DK7191D0 (da) Topisk salve
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
GR1001151B (el) Νεα xρηση θειορεδοξινης
DE69101219D1 (de) Lipase enthaltendes flüssiges einweichmittel und dessen verwendung.
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
DE59106803D1 (de) Substituierte Pyrido-oxazine.
DE59006159D1 (de) Verwendung von macrolactonen als antiallergica.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
FI961339A0 (fi) Triaryylieteenijohdannaiset käytettäväksi hoidossa
ATE209647T1 (de) Pyridiniumsalze und ihre verwendung zur bekämpfung von helicobacter-bakterien

Legal Events

Date Code Title Description
R071 Expiry of right

Ref document number: 625055

Country of ref document: EP